Ludwig In the News

December 25, 2021
Tap into Princeton

Ludwig Princeton’s Yibin Kang has discovered a new compound that disables a protein, metadherin, that plays a role in many major cancers. The compound is currently in preclinical development for evaluation in human trials.

December 14, 2021
News 12 The Bronx

In this video interview, Ludwig Princeton’s Yibin Kang discusses his research on the MTDH gene, its central role in cancer metastasis and how he and his colleagues are targeting the gene.

September 16, 2021
Fierce Biotech

A study led by Ludwig Harvard’s Stephen Elledge employed CRISPR to probe the effects of mutations to thousands of genes in cancer. The study, published in Sciencediscovered in mouse models that mutations to more than 100 tumor suppressor genes prevent the immune system from detecting and destroying cancer cells.

September 16, 2021

A study led by Ludwig MIT’s Tyler Jacks, published in Cell, showed that vaccinating against a subset of cancer antigens generated by random mutations, or neoantigens, can boost the killing of cancer cells by reawakening dormant T cells that target those neoantigens in mice bearing lung tumors.

September 3, 2021

Ludwig Oxford’s Benoit Van den Eynde and Carol Leung, in collaboration with the labs of Oxford’s Adrian Hill and Irina Redchenko, led a study published in the Journal for ImmunoTherapy of Cancer on a new therapeutic cancer vaccine regimen. The regimen, which includes the vector used in the Oxford-AstraZeneca COVID-19 vaccine and is equipped with two cancer antigens discovered and developed by Ludwig researchers, drives the infiltration of cancer-killing T cells into tumors.

Additional coverage: The Times* | Daily Mail | Daily Express 

August 6, 2021
La Repubblica

Italian newspaper La Repubblica interviewed Ludwig Lausanne’s George Coukos about breast cancer and Lausanne’s new cellular therapy trial.

July 16, 2021
Science Times

Ludwig MIT’s Sangeeta Bhatia led a study, published in Nature Materials, which assesses a multimodal nanosensor that noninvasively reveals the presence of cancer-associated proteins through a urine test and pinpoints tumors’ locations via PET imaging.

July 5, 2021
Oncology Times

Ludwig Lausanne’s Douglas Hanahan spoke with Oncology Times about his recently published research in Cancer DiscoveryThe study identified a previously unrecognized mechanism by which cancer cells of a relatively benign subtype of pancreatic tumors methodically revert to a progenitor state of cellular development to spawn highly aggressive tumors. These tumors are capable of metastasis to the liver and lymph nodes.

May 17, 2021
Dallas Innovates

Ludwig San Diego’s Beata Mierzwa was honored as a female STEM leader by Lyda Hill Philanthropies’ IF/THEN Initiative, which opened in Dallas, Texas in May 2021.

April 29, 2021
TIME magazine

Ludwig Scientific Director Chi Van Dang and co-authors note in this essay that the Cancer Moonshot program, launched under the leadership of then Vice President Biden, has made significant progress, though major challenges remain.

April 22, 2021

During Week 1 AACR Annual Meeting 2021, Ludwig Princeton’s Josh Rabinowitz spoke about his ongoing studies on whether ketogenic diets can slow tumor growth.

April 16, 2021
*The Cancer Letter

The Ludwig Institute for Cancer Research established a branch at Princeton University that will be wholly dedicated to the study of cancer metabolism and the translation of its findings into new paradigms for cancer prevention and treatment.

April 16, 2021
New Jersey Business Magazine

Ludwig Cancer Research announced on its 50th anniversary the launch of the newest branch based at Princeton University which will be wholly dedicated to the study of cancer metabolism and the translation of its findings into new paradigms for cancer prevention and treatment.

April 13, 2021

Ludwig Cancer Research announces the launch of its newest Branch, based at Princeton University and wholly dedicated to the basic and translational study of cancer metabolism.

April 8, 2021
Endpoint News

In this interview with Endpoint News, Ludwig MIT’s Sangeeta Bhatia speaks about gender inequality in the biotechnology industry.

March 8, 2021
Cancer Cell

To commemorate International Women’s Day, Ludwig scientist Johanna Joyce spoke about the healthy “microenvironments,” with supportive mentors and successful female professors, that she encountered in her journey through academia.

February 14, 2021
The Guardian

Linda Bauld, who chairs a session at the upcoming Cancer Prevention – Physical Activity conference convened by Ludwig Cancer Research and Cancer Research UK, spoke on the importance of exercise as a cancer prevention tool.

February 2, 2021
Le Temps

Ludwig Lausanne Director George Coukos discusses the Branch’s work, the impact the pandemic has had on research and the hope he has for the effectiveness of second generation TIL therapies. This article is in French.

February 2, 2021

Ludwig Lausanne Director George Coukos spoke with 24Heures about the Branch’s program to develop cutting edge immunotherapies, their potential impact and the Branch’s future research projects.This article is in French.

January 20, 2021
Cancer Discovery

Many scientific leaders and advocates anticipate cancer-related issues will be given high priority in the new Biden Administration. Ludwig Institute Scientific Director Chi Van Dang and others comment on what to expect and what ought to be prioritized in a “Cancer Moonshot 2.0.”


You are now leaving Ludwig Cancer Research's website and are going to a website that is not operated by the association. We are not responsible for the content or availability of linked sites. Do you wish to continue?